Skip to main content

Table 2 Roles of miR-637 in vivo and in vitro

From: Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis

Diseases

Targets

Effects in vitro

Cell lines

Effects in vivo

Laboratory animals

Ref

GBM/LGG

AKT1

growth↓, invasion↓, and migration↓

U251 and U87

tumorigenesis↓

nude mice

[9]

HMGA1

proliferation↓, invasion↓, and migration↓

U251 and U87

tumor growth↓

nude mice

[42]

CDK6

proliferation↓ and invasion↓

LN18

—

—

[50]

GBM

WNT7A

proliferation↓

U251 and LN229

tumor growth↓

BALB/c mice (4 weeks)

[10]

PTC

HEMGN

cell cycle↓, proliferation↓, migration↓, and apoptosis↑

TPC-1 and SW579

tumor growth↓

BALB/c mice (5 weeks)

[12]

AKT1

proliferation↓, invasion↓, and migration↓

TPC-1 and HTH83

tumorigenesis↓

female BALB/C nude mice (8–12 weeks)

[13]

TC

KLK4

migration↓ and apoptosis↑

K1 and TPC-1

tumor growth↓

female BALB/C nude mice (5 weeks)

[52]

NSCLC

—

proliferation↓, invasion↓, and migration↓

H1299 and HCC827

—

—

[14]

GC

CALA

apoptosis↑

AGS

—

—

[55]

APLN

proliferation↓, invasion↓, and apoptosis↑

SGC-7901

—

—

[15]

MMP19

invasion↓ and migration↓

BGC823 and MGC803

—

—

[16]

AKT1

invasion↓ and migration↓

SGC-7901 and AGS

—

—

[17]

HCC

LIF

growth↓ and apoptosis↑

HepG2 and Bel7404

tumor growth↓

female BALB/c nude mice (4–6 weeks)

[21]

USP21

proliferation↓ and invasion↓

HepG2 and Hep3B

—

—

[51]

AKT1

proliferation↓ and invasion↓

Huh-7 and Sk-Hep-1

—

—

[20]

AKT1

proliferation↓ and invasion↓, migration↓

Huh7 and MHCC-97H

—

—

[18]

CRC

NUPR1

invasion↓ and migration↓

HCT116 and HT29

—

—

[22]

WNT1

invasion↓, migration↓, and apoptosis↑

HCT116 and SW480

—

—

[56]

PDAC

AKT1

growth↓ and apoptosis↑

Capan-2 and BxPC-3

—

—

[23]

CHOL

LY6E

proliferation↓, invasion↓, migration↓, and apoptosis↑

HuCCT1 and RBE

tumor growth↓, metastasis ↓

nude mice

[36]

CTSB

proliferation↓ and migration↓

QBC939

—

—

[24]

OSCC

NUPR1

proliferation↓

SCC-9 and HSC-2

—

—

[25]

NUPR1

growth↓, invasion↓, EMT↓, and apoptosis↑

Tca8113 and SCC-9

tumor growth↓, EMT↓

BALB/c nude mice (4–6 weeks)

[35]

ccRCC

—

invasion↑ and migration↑

Caki1 and ACHN

—

—

[40]

OC

KLK4

proliferation↓, invasion↓, and migration↓

OVCAR-3 and H8910

—

—

[28]

PLXNB2

proliferation↓, invasion↓, migration↓, and apoptosis↑

SKOV3 and CAOV3

tumor growth↓

BALB/c nude mice

[27]

TNBC

LIF

cell cycle↓, apoptosis↑, and autophagy↑

MDA-MB-231

tumor growth↓, metastasis ↓

female nude mice

[29]

AKT1

proliferation↓ and migration↓

BT-549 and MDA-MD-231

tumorigenesis ↓, migration ↓, metastasis ↓

female BALB/c nude mice

[37]

AKT3

—

—

tumor growth↓

female BALB/c nude mice

CCa

RING1

proliferation↓

SiHa and C-4 I

tumor growth↓

nude mice

[30]

SaOS

STAT3

invasion↓ and migration↓

U2OS and SW1353

—

—

[31]

HDAC4

proliferation↓, invasion↓, and migration↓

HOS and U2OS

—

—

[32]

MM

NUPR1

proliferation↓, apoptosis↑, and autophagy↓

U266 and RPMI8226

—

—

[33]

CML

ABL1

proliferation↓ and apoptosis↑

K562

—

—

[34]

  1. GBM glioblastoma multiforme, LGG low-grade glioma, PTC papillary thyroid carcinoma, TC thyroid gland carcinoma, NSCLC non-small cell lung cancer, GC gastric cancer, HCC hepatocellular carcinoma, CRC colorectal cancer, PDAC pancreatic ductal adenocarcinoma, CHOL human cholangiocarcinoma, OSCC oral squamous cell carcinoma, ccRCC clear cell renal cell carcinoma, OC ovarian cancer, TNBC triple-negative breast cancer, CCa cervical cancer, SaOS osteosarcoma, MM multiple myeloma, CML chronic myeloid leukemia, EMT epithelial-mesenchymal transition